Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astri Therapeutics Inc
(NQ:
ATXS
)
11.74
-0.19 (-1.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astri Therapeutics Inc
< Previous
1
2
3
4
5
Next >
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q2 2024
August 12, 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 12, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema
August 12, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference
August 07, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
Astria Therapeutics
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
May 30, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
May 24, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
May 23, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q1 2024
May 09, 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 09, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
May 08, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
April 09, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
March 25, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...
Via
Benzinga
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023
March 04, 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
March 04, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
February 20, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
January 30, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 25, 2024
Via
Benzinga
$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying
December 26, 2023
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress
November 27, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.